- Agribiotech Capitalizes on Methods Developed by
Pharmaceutical Labs.
As the media and investors have focused on the commercial potential of pharmaceutical research in recent years, human genomics and proteomics have risen to a ......
- Random Samples.
Companies: Pasteur Sanofi Diagnostics has agreed to accept Bio-Rad Laboratories' $210 million buyout offer. The deal is expected to close in 90 days...TSI Incorporated's board ......
- Random Samples.
Companies: Glyko, a subsidiary of BioMarin Pharmaceutical, acquired the key assets of the Biochemical Research Reagent Division of Oxford GlycoSciences Plc. The purchase agreement is ......
- Thomas P. Livingston Elected Secretary of PECorporation.
Business Editors/Legal Writers NORWALK, Conn.--(BUSINESS WIRE)--March 30, 2000 PE Corporation announced today the election of Thomas P. Livingston as secretary of the Corporation. Mr. Livingston, ......
- Celera Genomics Appoints Jason Molle as Senior VicePresident of Sales and Marketing.
Business Editors/Health & Medical Writers ROCKVILLE, Md.--(BW HealthWire)--June 30, 2000 Celera Genomics (NYSE:CRA), a PE Corporation business, announced today that Jason Molle, has joined Celera ......
- PE Biosystems To Acquire Third WaveTechnologies.
Health/Medical Writers FOSTER CITY, Calif., and MADISON, Wisc.--(BW HealthWire)--Jan. 24, 2000 PE Biosystems (NYSE:PEB), a PE Corporation business, and Third Wave Technologies, Inc., a privately-held ......
- Celera Genomics Appoints Chief Operating Officer;Peter Chambre, CEO of Bespak plc to Lead...
Business Editors/Health & Medical Writers ROCKVILLE, Md.--(BW HealthWire)--July 3, 2000 Celera Genomics (NYSE:CRA), a PE Corporation business, announced today that Peter Chambre has been appointed ......
- PerSeptive Biosystems, Inc. Secures $6 Million in Additional Funding.
FRAMINGHAM, Mass.--(Health Wire)--June 1, 1995--PerSeptive Biosystems, Inc. (Nasdaq: PBIO) today announced that it has secured 8.5 million DM (approximately $6 million) in bank loans from ......
- Court Issues Recommendation On Claims Construction ina Suit Between PE Biosystems and...
Business Editors/Health & Medical Writers FOSTER CITY, Calif.--(BW HealthWire)--Feb. 29, 2000 PE Biosystems Group (NYSE:PEB), a PE Corporation business, today announced that U.S. Magistrate Judge ......
- PE Corporation Appoints Kenneth D. Noonan Senior VicePresident, Corporate Development.
Business Editors & Health/Medical Writers NORWALK, Conn.--(BW HealthWire)--Jan. 5, 2000 PE Corporation announced today that Kenneth D. Noonan, Ph.D., 51, has been appointed senior vice ......
- PE Biosystems Appoints Deborah A. Smeltzer VicePresident, Finance.
FOSTER CITY, Calif.--(BW HealthWire)--November 18, 1999-- PE Biosystems (NYSE:PEB), a PE Corporation business, announced today that Deborah A. Smeltzer, 46, has been appointed vice president, ......
- PERSEPTIVE BIOSYSTEMS REACHES SALES MILESTONE; SELLS 500th BioCAD(TM) WORKSTATION.
CAMBRIDGE, Mass.--(HealthWire)--February 15, 1995--PerSeptive Biosystems, Inc. (Nasdaq-NMS: PBIO) today announced that it has reached a sales benchmark with the sale and shipment of the 500th ......
- PERSEPTIVE BIOSYSTEMS COMPLETES RELOCATION TO NEW HEADQUARTERS.
Framingham, MA--(HealthWire)--April 18, 1995--PerSeptive Biosystems, Inc. (Nasdaq-NMS: PBIO) today announced completion of the Company's relocation to its new Framingham headquarters at 500 Old Connecticut Path....
- PerSeptive Biosystems Announces Agreement in Principle to Settle Securities Litigation.
FRAMINGHAM, Mass.--(Health Wire)--May 30, 1995--PerSeptive Biosystems, Inc. (Nasdaq: PBIO) today announced that an agreement in principle has been reached to settle the pending class action ......
- PerSeptive Biosystems, Inc. Announces Third Quarter Financial Results; Product Sales Grow...
FRAMINGHAM, Mass--(HealthWire)--August 2, 1995--PerSeptive Biosystems, Inc. (NASDAQ: PBIO) today announced its results for the third quarter of fiscal 1995. For the three months ended June ......